Biochemical Study on Fibroblast growth factor 23(FGF23) and its relation with Chronic Kidney Disease
Research Journal of Pharmacy and Technology, ISSN: 0974-360X, Vol: 16, Issue: 1, Page: 115-118
2023
- 6Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Article Description
The research involved study the relation between FGF23 and some of the biochemical parameters related to the chronic kidney disease(phosphate, vitamin D, calcium, urea, creatinine, chloride, potassium, albumin, alkaline phosphatase enzyme (ALP), transamination enzymes GOT and GPT)in serum blood patients compared with control group, the result demonstration is a significant increase in the mean concentration rate FGF23(324. 06± 291.1pg/ml) in patients compared with mean concentration in control group was ( 273±188.5pg/ml), also the result showed a significant increase in the concentration of (phosphate, urea, creatinine, potassium, ALP) and a significant decrease had been shown in the concentration of (vitamin D, calcium, albumin, GOT and GPT enzymes). while the results had been showed a non-significant increase in chloride in patients compared with control group, Correlation coefficient of FGF23 with these clinical parameters showed a negative significant correlation with( phosphate, vitamin D, Albumin) while FGF23 elucidated a positive significant correlation with calcium while the result showed a non-significant correlation with rest of the biochemical parameters, conclusion of this study was that FGF23 concentration correlated significantly in hyperphosphatemia, decrease vitamin D and calcium in chronic kidney disease CKD.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know